CE Instructions for
WB4460R: COVID-19 Vaccine Training: General Overview of Immunization Best Practices for Healthcare Providers
(Credit expires 12/15/2024)

To receive continuing education (CE)
In order to receive continuing education (CE) for WB4460R COVID-19 Vaccine Training: General Overview of Immunization Best Practices for Healthcare Providers, please visit TCEO at www.cdc.gov/getCE  and follow the 9 Simple Steps by 12/15/2024. 
NOTE—You must pass the posttest at 80%. There are only 2 attempts allowed.

If you have any questions or problems, contact CDC/ATSDR Training and Continuing Education Online via email at ce@cdc.gov. You may also contact the CE Coordinator at NCIRD, Melissa Barnett at MBarnett2@cdc.gov

PROGRAM DESCRIPTION: CDC has created a new, web-on-demand, self-paced module for healthcare providers who will be administering COVID-19 vaccine. This module will provide healthcare providers with information about COVID-19 vaccine Emergency Use Authorization and safety, as well as general information about vaccine storage, handling, administration, and reporting.

OBJECTIVES: At the conclusion of the session, the participant will be able to:
Describe the Vaccine Safety, Development, and Emergency Use Authorization (EUA) mechanism to provide approval for COVID-19 vaccines.
Describe the general storage and handling requirements for COVID-19 vaccines.
Describe the general vaccine administration procedures for COVID-19 vaccines.
Describe documentation and reporting procedures for  adverse events associated with COVID-19 Vaccines.
Locate current immunization resources to increase knowledge of team’s role in program implementation for improved team performance.
Implement disease detection and prevention health care services (e.g., smoking cessation, weight reduction, diabetes screening, blood pressure screening, immunization services) to prevent health problems and maintain health.

Andrew Kroger,  MD, MPH, Medical Officer, CDC/NCIRD
JoEllen Wolicki, BSN, RN, Nurse Educator, CDC/NCIRD

ORIGINATION DATE: 12/15/2020         RENEWAL DATE:  12/15/2022                         EXPIRATION DATE: 12/15/2024

URL: https://www2.cdc.gov/vaccines/ed/covid19/SHVA/index.asp
HARDWARE/SOFTWARE: Computer Hardware; Internet connection; Browser; MATERIALS: Internet connection and computer
TARGET AUDIENCE: Administrators, CHES certified health educators, Physicians, Epidemiologists, LPNs, LVNs, Medical assistants, medical students, NPs, nurse technicians, other health educators, Pharmacists, PAs, program managers RNs
PREREQUISITES: Participants should have a basic educational background in science including general knowledge in the subject areas of biology, immunization, and vaccine-preventable diseases.

FORMAT: This course is Enduring material.
CE Logo In support of improving patient care, The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME:  The Centers for Disease Control and Prevention designates this Enduring activity for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE:  The Centers for Disease Control and Prevention designates this activity for .25 nursing contact hours.

CPE: The Centers for Disease Control and Prevention designated this knowledge-based event for pharmacists to receive .025 CEUs (.25 contact hours) in pharmacy education. The Universal Activity Number is JA4008229-0000-22-131-H06-P.

Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline.  Official credit will be uploaded within 60 days on the NABP/CPE Monitor.

DISCLOSURE: In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies during the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.  

CDC, our planners, and content experts wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.

FEES: No fees are charged for CDC’s CE activities.